A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder

NCT05664516 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Binge-eating Disorder

Interventions

DRUG: TNX-1900 (Tonix Pharmaceuticals)
DRUG: Placebo

Sponsor

Massachusetts General Hospital